Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Fosgonimeton Phase 1 Trials M3 Biotechnology (later Athira Pharma) completes Phase 1 safety trials of fosgonimeton, a prodrug of Dihexa
This is why understanding the safety profile and risks of individual peptides is essential before designing any research protocol for autoimmune applications
GLP-1 receptor agonists reduce appetite primarily through the hypothalamus and vagal afferent pathways
BPC-157 (Body Protection Compound-157) is a synthetic version of a protein naturally found in the stomach
In plain terms, the peptide is built from mirror-image amino acids in reverse order
US$ 21.55
US$ 28.28
US$ 24.31
US$ 27.39
US$ 21.77
US$ 29.19
US$ 20.99
US$ 28.08
US$ 23.42
US$ 23.09
